Medifast (OPTAVIA) Q2 Revenue Down 43,1% To $169 Million

Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2024.

Revenue of $168.6 million, with revenue per active earning Coach of $4,972
Independent active earning OPTAVIA Coaches of 33,900
Net loss of $8.2 million (non-GAAP adjusted net income of $10.1 million)
Loss per diluted share of $0.75 (non-GAAP adjusted earnings per share (“EPS”) of $0.92)
Cash, Cash Equivalents, and Investment Securities of $163.5 million with zero debt

“We are acting decisively to transform our business to position us for long-term growth, with a strong balance sheet free of debt, a clear focus on new customer acquisition, and a broader health and wellness offer to a significantly expanded target market,”

said Dan Chard, Chairman & CEO.

”Our holistic approach, encompassing nutrition, personalized coaching, a supportive community, and access to a clinician through our collaboration with telehealth provider, LifeMD, positions us uniquely to support those who are interested in weight loss medications as well as those who are transitioning off a medical regimen, or those who choose to pursue more traditional weight loss methods. Our mission today, much like it has been over the last 40 years, is to help our

Read more...

Leave a Reply

Your email address will not be published. Required fields are marked *